Extracorporeal Magnetotransduction Therapy (EMTT®) is an advanced, non-invasive modality designed to support regeneration, rehabilitation, and pain reduction in musculoskeletal conditions. By delivering high-energy electromagnetic pulses, EMTT enables clinicians to expand treatment options while minimizing risk, downtime, and patient recovery timelines.
In October 2020, CuraMedix partnered with Prof. Dr. Ludger Gerdesmeyer to introduce Extracorporeal Magnetotransduction Therapy (EMTT) and STORZ Medical’s MAGNETOLITH to the U.S., expanding access to advanced regenerative technologies. View this webinar for the latest updates on EMTT technology and treatment advancements.
What Makes EMTT Different?
EMTT operates via high-energy electromagnetic stimulation, whereas Extracorporeal Shockwave Therapy (ESWT) relies upon acoustic waves. While the mechanisms differ, the two modalities are highly complementary and are frequently used together to address both local tissue pathology and broader regional dysfunction.
Key advantages of EMTT include:
- Non-invasive, outpatient treatment with minimal side effects
- Broad application across musculoskeletal conditions
- High patient comfort with efficient workflows
- Strong compatibility with ESWT/EPAT protocols
- Compatible with Orthobiologics, like PRP.
MAGNETOLITH: Expanding Clinical Possibilities
EMTT distinguishes itself from other electromagnetic therapies by its high oscillation frequency (100–300 kHz), which enables deeper tissue penetration and broader treatment applications.
For clinicians, this translates to a streamlined, efficient treatment experience with adjustable pulse settings and minimal patient preparation. Treatments typically last 5–20 minutes and can be repeated over a short series, depending on the indication.
How EMTT Works: Clinical Mechanism
EMTT delivers high-energy magnetic pulses (≥10 mT) to targeted tissue, influencing cellular activity at a physiological level.
These effects include:
- Modulation of membrane potential
- Activation of ion channels
- Restoration of cellular homeostasis
By supporting membrane permeability and reactivating cellular processes such as the sodium-potassium pump, EMTT helps normalize tissue function in areas of dysfunction.
EMTT: Targeted Applications Backed by Research
EMTT supports regenerative healing, modulates inflammation, and provides analgesic effects across a range of musculoskeletal conditions. Key studies include:
Medial Meniscal Tear
A case report by Prof. Dr. Karsten Knobloch highlights the combined use of EMTT and focused shockwave therapy for symptomatic medial meniscal tears. Published in the Journal of Regenerative Science, results demonstrate improved outcomes using a non-invasive, synergistic approach.
Non-Specific Low Back Pain
A prospective randomized controlled trial by Prof. Dr. Ludger Gerdesmeyer shows EMTT significantly reduces pain and improves function in patients with non-specific low back pain. Published in the Journal of Orthopaedics, findings support EMTT as an effective, evidence-based treatment option.
Management of Musculoskeletal Disorders
A randomized, double-blind, placebo-controlled trial demonstrates that EMTT significantly reduces pain and improves physical function in knee osteoarthritis, rotator cuff enthesopathy, and lumbar spondyloarthrosis. These findings support EMTT as an effective, non-invasive option for managing chronic musculoskeletal conditions with sustained clinical benefit.
Soft Tissue Healing & Regenerative Potential (MSC Stimulation)
Research published in Electromagnetic Biology and Medicine demonstrates that EMTT stimulates human bone marrow mesenchymal stem cells without adverse effects. Led by Prof. Dr. Ludger Gerdesmeyer and Dr. Amol Saxena, this study highlights EMTT’s potential in advancing soft tissue regeneration and orthopedic applications.
Clinical Applications of EMTT
EMTT can be incorporated across a wide range of indications, including:
- Degenerative joint conditions (e.g., osteoarthritis)
- Chronic pain syndromes (e.g., low back pain, radiculopathy)
- Tendon disorders and overuse injuries
- Sports-related inflammation and joint dysfunction
- Post-surgical recovery support
- Muscle relaxation and improved range of motion
Its ability to address both acute and chronic conditions makes it a versatile addition to modern regenerative care and treatment plans.
Integrating EMTT into Clinical Practice
EMTT is designed for ease of integration. Treatments are delivered with the applicator positioned over the target region, and the patient remains comfortably clothed; the practitioner requires minimal setup.
Clinicians can tailor pulse intensity and frequency based on the indication, efficiently treating localized or larger regions. EMTT may be administered by physicians or trained staff, supporting scalability within the practice.
Why Combine EMTT with Shockwave?
EMTT and Shockwave therapy address different aspects of tissue healing. Shockwave targets localized mechanical and biological responses, while EMTT influences broader cellular and metabolic processes.
Together, they create a complementary treatment strategy that enhances tissue regeneration, improves pain outcomes, and supports more comprehensive care plans.
As noted by Dr. Karsten Knobloch, this combination can accelerate healing in tendons and bone, which is particularly relevant in high-performance and complex cases.
Ready to Harness the Power of EMTT?
CuraMedix partners with medical professionals to integrate evidence-based, non-surgical technologies into clinical practice. With the MAGNETOLITH Ultra+, providers can expand treatment capabilities while delivering efficient, patient-centered care.
Explore how EMTT can strengthen both clinical outcomes and practice performance.
3 Key Takeaways: EMTT at a Glance
1. EMTT Targets Cellular Function
By delivering high-energy electromagnetic pulses, EMTT influences the membrane potential and cellular signaling, thereby supporting tissue repair and pain modulation at the source.
2. EMTT complements Shockwave for Better Outcomes
EMTT and shockwave therapy address different aspects of healing. Used together, they create a more comprehensive, synergistic treatment approach.
3. EMTT expands Non-Invasive Treatment Options
From low back pain to degenerative joint conditions, EMTT provides clinicians with a versatile, evidence-based tool to enhance patient outcomes without surgery or downtime.
Frequently Asked EMTT Questions
What Conditions Can Extracorporeal Magnetotransduction Therapy Treat?
EMTT is used for musculoskeletal conditions such as osteoarthritis, chronic pain, tendon disorders, sports injuries, and degenerative joint diseases.
Explore conditions EMTT can treat.
How is Extracorporeal Magnetotransduction Therapy Different from Shockwave Therapy (ESWT/EPAT)?
Extracorporeal Magnetotransduction Therapy uses high-energy electromagnetic pulses, while Shockwave therapy uses acoustic waves; the two modalities work differently but are highly complementary.
Learn how EMTT differs from Shockwave therapy.
Is Extracorporeal Magnetotransduction Therapy Safe and Non-Invasive?
Yes, Extracorporeal Magnetotransduction Therapy is a non-invasive, outpatient treatment with minimal side effects and no required downtime.
Discover CuraMedix non-invasive treatment options.
Can Extracorporeal Magnetotransduction Therapy be Combined with Other MSK Treatments?
Yes, Extracorporeal Magnetotransduction Therapy is commonly combined with ESWT/EPAT and other non-surgical therapies to enhance clinical outcomes.
See how EMTT combines with regenerative therapies.
Is Extracorporeal Magnetotransduction Therapy Supported by Clinical Evidence?
Yes, Extracorporeal Magnetotransduction Therapy is evidence-based and supported by multiple clinical studies across various musculoskeletal indications.
Review the clinical evidence behind EMTT.
Review the clinical evidence behind EMTT.
Who is a Good Candidate for Extracorporeal Magnetotransduction Therapy?
Patients with musculoskeletal pain or dysfunction who are seeking a non-surgical treatment option may be good candidates for Extracorporeal Magnetotransduction Therapy.
Find out who benefits most from EMTT.
